Call Us Today @ 0172 - 4680800 | info@indswift.com | NSE - BSE

 Ind-Swift has filed more than 680 dossiers for registration in more than 20 Countries around the world stretching from South America to Philippines.

 It has developed Netazoxanide Anti-Diarrheal drug for the first time in India after successful clinical trials and bio-equivalence studies.

 It has strong capacity to develop non infringing API's requiring Complex Chemistry and Multiple reactions.

 Ind-Swift has developed taste masking technology of macrolides for the first time in India.

 Ind-Swift has developed the sustained release process of Isoxsuprine HCL tablets for the first time in India.

 Ind-Swift has developed the mouth desolving tablet.